Meyka Pro banner
Mesa Laboratories, Inc.

Mesa Laboratories, Inc. (MLAB) Stock Overview

Explore Mesa Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MLABNASDAQ
HealthcareMedical - Equipment & Services
$124.76
$5.61(4.71%)
U.S. Market opens in 58h 45m

Mesa Laboratories, Inc. (MLAB)

Meyka AI Score

Z

Key Financials

Market Cap698.1M
P/E Ratio143.66
EPS (TTM)$9.91
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$104.86
3 Months$84.93
1 Year Target$90.26

MLAB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Mesa Laboratories, Inc. (NASDAQ: MLAB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Mesa Laboratories, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MLAB on the NASDAQ shows an RSI of 71.61, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $90.26 for the NASDAQ listing.

Key metrics behind Mesa Laboratories, Inc.'s NASDAQ-traded stock include a P/E ratio of 143.66 and a market capitalization of 698.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MLAB on the NASDAQ.

Price Performance (NASDAQ: MLAB)

1-Day Change
4.71%
5-Day Change
10.32%
1-Month Change
27.95%
3-Month Change
14.34%
6-Month Change
33.62%
Year-to-Date (YTD) Change
58.93%
1-Year Change
86.46%
3-Year Change
-9.08%
5-Year Change
-53.99%
All-Time (Max) Change
4058.67%

Contact Information

303 987 8000
12100 West Sixth Avenue, Lakewood, CO, 80228

Company Facts

7,170 Employees
IPO DateFeb 29, 1984
CountryUS
Actively Trading

Frequently Asked Questions